Targeted Navigation in Hepatocellular Carcinoma (HCC)
- Trial number:
- NCT06260943
- Trial phase:
- N/A
- Study type:
- Any
- Overall status:
- Recruiting
Study start date
Scientific title
Summary
HCC Patients:
Enrolled or eligible for enrollment in Unified Prospective Registry and Biorepository of Patients with Chronic Liver Disease or Hepatobiliary Cancers Including Hepatocellular Carcinoma (HCC) and Cholangiocarcinoma.Diagnosis of hepatocellular carcinoma, confirmed by clinical chart review and International Classification of Diseases, Tenth Revision (ICD-10) C22.0. Adults, age 18 or older Able to provide informed consent
All other interviewees:
Advocates who will self-identify as having had HCC.Others who self-identify as either a caregiver or support person of an HCC patient.
Physicians/Licensed Independent Practitioners, Social Workers, Nurse Navigators, and Research Coordinators will all self-identify as being involved in the care of HCC patients.